Native Bordetella Pertussis Toxin
Specification
Related Products
| Cat#: |
BOP-023 |
| Product Name: |
Native Bordetella Pertussis Toxin |
| Description: |
Bordetella pertussis toxin (frozen) has been developed in response to the increasing pressure on the IVD industry to supply highly specific, cost-effective antibody capture systems, which are needed for monitoring vaccination programmes. The toxin undergoes two rounds of FHA (Filamentous Haemagglutinin) removal and manufacturing procedures are geared to ensure minimal lot to lot variation. Liquid presentation is the optimal presentation for minimising aggregation, for providing bulk lots to IVD, and for ease of aliquoting, freeze/thawing and storage. |
| Gene: |
Toxin |
| Species: |
Bordetella Pertussis |
| Synonyms: |
Bordetella Pertussis Toxin |
| Formulation: |
0.05M sodium phosphate and 0.5M sodium chloride at pH 7.2. |
| Concentration: |
0.25 mg/mL |
| Purity: |
>98% pure by SDS-PAGE; migrates as five bands(two doublets)when run under denaturing polyacrylamide SDS-urea gels. |
| Storage: |
Short Term Storage: Stable as a liquid at room temperature for at least 2 months.
Long Term Storage: Aliquot and store at -20 centigrade to-80 centigrade.Do not freeze thaw multiple times. When thawing. swirl tube gently for l minute to fully redissolve. |
| Shipping: |
This product is shipped at ambient temperature. Extensive stability tests have shown no negative effects on antigen performance for 7 days of shipping including several freeze/thaw cycles. |
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
